Successful treatment of chronic hepatitis C virus infection in a patient receiving daily peritoneal dialysis.
CONCLUSION: A patient with end-stage renal disease requiring PD was treated successfully for HCV genotype 1a infection with PrOD fixed-dose combination therapy plus ribavirin therapy. The patient achieved an SVR12 despite withdrawal of ribavirin at treatment week 10, with minimal adverse effects reported.
PMID: 28947525 [PubMed - in process]
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Stark JE, Cole J Tags: Am J Health Syst Pharm Source Type: research
More News: Anemia | Dialysis | Epogen | Hepatitis | Hepatitis C | Norvir | Peritoneal Dialysis | Procrit | Renal Failure | Sodium | Transplants | Virology